Backed by a wealth of experience in life sciences and healthcare, the fund manager has effectively engaged in numerous investment rounds, totaling over 50 deals. With a strategic emphasis on early-stage ventures, they have successfully navigated the European and North American markets, resulting in notable exits that highlight their operator-first approach. Their portfolio reflects a commitment to innovative therapeutics and digital health solutions, showcasing a data-driven investment style that fosters growth and sustainability.